Formulation and
reformulation.
GCRC develops new cannabinoid formulations and improves existing ones for cannabis and plant medicine businesses that need a workable formula, a prototype or a clear route to production.
A new product, or a better one.
Choose where your project starts. Both paths end with a formula ready for your production partner.
Developing a new product
For brands with a product idea that needs a real formula. We work from the intended format and audience to a prototype you can evaluate.
- Ingredient and cannabinoid selection, including minor and acidic cannabinoids
- Intended format and dose presentation
- Flavor, terpene and delivery considerations
- Prototype development and review
- Preparation for manufacturing
Improving an existing product
For products already on the market or in production that need to change. We start with the actual problem, not a generic checklist.
- Taste and texture
- Ingredient compatibility
- Delivery and absorption format
- Batch to batch consistency
- Changed product or market requirements
- Entire brand reformulation or a single product
Planning for stability
Stability planning is offered as a development service within a project. We help plan how a formula should hold up over time and in its packaging, and what testing it will need.
- Stability considerations for the chosen format
- Packaging and storage factors
- Testing plan with your laboratory or manufacturer
Phyto food science and formulation.
GCRC offers a unique phyto food science and formulation service. Please get in touch with us with your needs.
- Hemp seed protein and plant nutrition concepts
- Functional foods built around whole plant ingredients
- Recipe and ingredient development for phyto food products
- Guided by the work of the Phytofood Research Initiative
What GCRC can take on.
Engage GCRC for a single task or a full development program. New service areas are added as the practice grows.
New product formulation
From concept to a prototype you can test.
Existing product reformulation
Fix taste, texture, compatibility or consistency.
Cannabinoid formulation strategy
Which cannabinoids, in what ratios and why.
Minor cannabinoid formulation
Working beyond THC and CBD alone.
Acidic cannabinoid formulation
CBGa, CBDa and CBCa focused work.
Terpene formulation
Flavor, aroma and profile development.
Delivery system evaluation
Choosing the right format for the goal.
Ingredient evaluation
Quality, compatibility and sourcing review.
Product concept development
Shaping an idea into a product brief.
Formulation troubleshooting
Finding out why a product is not performing.
Research support
Linking formulation choices to evidence.
Prototype development
Samples for review before production.
Phyto food formulation
Plant nutrition and hemp seed based food concepts.
- Tinctures and oils
- Soft gels
- Oral syringes
- Topicals and balms
- Roll ons
- Functional beverages
A practical path from inquiry to production.
Project inquiry
Tell us the product, format, goal and timeline.
Scope discussion
We agree the work, fees, timeline and responsibilities.
Development
Ingredient selection, formulation and testing plan.
Prototype review
You evaluate the prototype and we refine it.
Manufacturing handoff
A documented formula for your production partner.
What does GCRC formulate?
GCRC formulates cannabinoid and plant based products such as tinctures, oils, soft gels, oral syringes, topicals and functional beverages, and reformulates existing products in those formats.
Can you work with our existing manufacturer?
Yes. GCRC prepares formulas for manufacturing handoff and can work alongside the manufacturer you already use.
Who owns the finished formula?
Formula rights are agreed in the individual project scope before development begins, together with fees, timelines and testing responsibilities.
Should I send our formula with the inquiry?
No. Describe the product and the problem first. Confidential formula files are requested only once a confidentiality agreement is signed.
Bring your project to the research table.
Partners, clients and research collaborators, tell us what you are building.